Suppr超能文献

基于高效液相色谱的方法分析中枢神经系统中 GABA 转运体的活性。

High performance liquid chromatography-based method to analyze activity of GABA transporters in central nervous system.

机构信息

Laboratory of Experimental Neuropharmacology, Federal University of Pará, Guamá, Belém, Pará, Brazil.

Laboratory of Neuroplasticity, Federal University of Pará, Umarizal, Belém, Pará, Brazil.

出版信息

Neurochem Int. 2022 Sep;158:105359. doi: 10.1016/j.neuint.2022.105359. Epub 2022 May 13.

Abstract

The GATs are the membrane proteins responsible for the uptake of GABA in the central nervous system. Alterations in GAT activity are implicated in several neurological diseases, including retinopathies. The present study describes an alternative method to determine GAT activity in tissue preparations of the central nervous system, using high performance liquid chromatography (HPLC) with fluorescence detection. The GABA concentration in the medium was determined using the o-phthaldehyde (OPA)-derivation protocol validated by the Brazilian Health Regulatory Agency (ANVISA) and the United States Food and Drug Administration (US-FDA). The GAT activity in the retinal preparations was determined through the evaluation of the GABA uptake, which was measured by assessing the difference between the initial and final concentrations of GABA in the incubation medium. The evaluation of the GAT kinetics returned values of K = 382.5 ± 32.2 μM and V = 34 nmol/mg of protein. The data also demonstrated that the GABA uptake was predominantly Na- and temperature-dependent, and was also inhibited by incubation with nipecotic acid, a substrate of GABA transporters. Taken together, these findings confirm that our approach provided a specific measure of GAT activity in retinal tissue. The data presented here thus validate, for the first time, an alternative, simple and sensitive method for the evaluation of GAT activity using high performance chromatography on preparations of the central nervous system.

摘要

GATs 是负责中枢神经系统中 GABA 摄取的膜蛋白。GAT 活性的改变与包括视网膜病变在内的几种神经疾病有关。本研究描述了一种替代方法,用于使用高效液相色谱(HPLC)结合荧光检测来确定中枢神经系统组织制剂中的 GAT 活性。使用巴西卫生监管机构(ANVISA)和美国食品和药物管理局(US-FDA)验证的邻苯二醛(OPA)衍生方案来确定介质中的 GABA 浓度。通过评估 GABA 的摄取来确定视网膜制剂中的 GAT 活性,这是通过评估孵育介质中 GABA 的初始和最终浓度之间的差异来衡量的。GAT 动力学的评估返回了 K 值=382.5±32.2 μM 和 V 值=34 nmol/mg 蛋白。该数据还表明 GABA 的摄取主要依赖于 Na+和温度,并且还可以通过与 GABA 转运体的底物——哌可酸孵育来抑制。综上所述,这些发现证实了我们的方法为视网膜组织中的 GAT 活性提供了一种特异性的测量方法。因此,这里呈现的数据首次验证了一种替代的、简单和敏感的方法,用于使用高效液相色谱法评估中枢神经系统制剂中的 GAT 活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验